Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

The high-risk, high-reward nature of the Russell 2000 makes stock selection critical, and we’re here to guide you toward the right ones. That said, here is one Russell 2000 stock that could be a breakout winner and two best left off your watchlist.

Two Stocks to Sell:

U.S. Physical Therapy (USPH)

Market Cap: $1.27 billion

With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE: USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States.

Why Does USPH Give Us Pause?

1. Revenue base of $781 million puts it at a disadvantage compared to larger competitors exhibiting economies of scale
2. Incremental sales over the last five years were less profitable as its 1.9% annual earnings per share growth lagged its revenue gains
3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 6 percentage points

U.S. Physical Therapy is trading at $83.16 per share, or 29x forward P/E. Dive into our free research report to see why there are better opportunities than USPH.

Lemonade (LMND)

Market Cap: $4.18 billion

Built on the principle of giving back unused premiums to charitable causes selected by policyholders, Lemonade (NYSE: LMND) is a technology-driven insurance company that offers homeowners, renters, pet, car, and life insurance through an AI-powered digital platform.

Why Does LMND Worry Us?

1. Performance over the past two years shows its incremental sales were less profitable, as its 15.8% annual earnings per share growth trailed its revenue gains
2. Annual book value per share declines of 5.9% for the past five years show its capital management struggled during this cycle
3. Push for growth has led to negative returns on capital, signaling value destruction

Lemonade’s stock price of $55.00 implies a valuation ratio of 9.1x forward P/B. Read our free research report to see why you should think twice about including LMND in your portfolio.

One Stock to Watch:

First BanCorp (FBP)

Market Cap: $3.31 billion

Tracing its roots back to 1948 in San Juan, First BanCorp (NYSE: FBP) is a bank holding company that provides commercial banking, consumer financing, mortgage services, and insurance products across Puerto Rico, the U.S. mainland, and the Caribbean.

Why Do We Like FBP?

1. Differentiated product suite is reflected in its Strong performance of its loan book leads to a High-yielding loan book and low cost of funds are reflected in its best-in-class net interest margin of 4.5%
2. Share repurchases have amplified shareholder returns as its annual earnings per share growth of 37.3% exceeded its revenue gains over the last five years
3. Impressive 20.1% annual tangible book value per share growth over the last two years indicates it’s building equity value this cycle

At $21.23 per share, First BanCorp trades at 1.5x forward P/B. Is now a good time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.